Integrating spatial epidemiology into a decision model for evaluation of facial palsy in children
Andrew M Fine1, John S Brownstein, Lise E Nigrovic
1Division of Emergency Medicine, Children's Hospital Boston, Boston, MA 02115, USA. andrew.fine@childrens.harvard.edu
Insights
A new diagnostic algorithm integrating public health data with clinical factors accurately identifies Lyme disease in children with facial palsy. This approach improves diagnosis over traditional methods, especially when considering geographic and seasonal risk factors.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Diagnostic algorithm development
Background:
- Facial palsy in children can be a symptom of Lyme disease.
- Accurate and timely diagnosis is crucial for effective treatment.
- Current diagnostic methods may not fully leverage available epidemiological data.
Purpose of the Study:
- To develop and validate a novel diagnostic algorithm for Lyme disease in pediatric patients presenting with facial palsy.
- To integrate public health surveillance data with clinical predictors for improved diagnostic accuracy.
- To assess the performance of the algorithm compared to clinical judgment alone.
Main Methods:
- Retrospective cohort study of 264 children (<20 years) with peripheral facial palsy evaluated for Lyme disease.
- Utilized multivariate regression to identify independent clinical and epidemiologic predictors.
- Integrated geographic incidence data and seasonal risk factors with clinical symptoms (fever, headache).
Main Results:
- The algorithm incorporating geographic and seasonal risk factors identified 100% of Lyme disease cases, outperforming clinical experts (72%).
- Key predictors included Lyme disease season (June-November), high-incidence counties, fever, and headache.
- Children with both geographic and seasonal risk factors had a significantly higher likelihood of Lyme disease.
Conclusions:
- Formal integration of geographically based incidence data into a clinical algorithm significantly improves Lyme disease diagnosis accuracy in children with facial palsy.
- This approach offers a more effective diagnostic tool than intuitive clinical assessment alone.
- Investments in health information technology can enhance communication between public health and clinical settings, leading to better patient outcomes.
Objective:
To develop a novel diagnostic algorithm for Lyme disease among children with facial palsy by integrating public health surveillance data with traditional clinical predictors.
Design:
Retrospective cohort study.
Setting:
Children's Hospital Boston emergency department, 1995-2007.
Patients:
Two hundred sixty-four children (aged <20 years) with peripheral facial palsy who were evaluated for Lyme disease.
Main Outcome Measures:
Multivariate regression was used to identify independent clinical and epidemiologic predictors of Lyme disease facial palsy.
Results:
Lyme diagnosis was positive in 65% of children from high-risk counties in Massachusetts during Lyme disease season compared with 5% of those without both geographic and seasonal risk factors. Among patients with both seasonal and geographic risk factors, 80% with 1 clinical risk factor (fever or headache) and 100% with 2 clinical factors had Lyme disease. Factors independently associated with Lyme disease facial palsy were development from June to November (odds ratio, 25.4; 95% confidence interval, 8.3-113.4), residence in a county where the most recent 3-year average Lyme disease incidence exceeded 4 cases per 100,000 (18.4; 6.5-68.5), fever (3.9; 1.5-11.0), and headache (2.7; 1.3-5.8). Clinical experts correctly treated 68 of 94 patients (72%) with Lyme disease facial palsy, but a tool incorporating geographic and seasonal risk identified all 94 cases.
Conclusions:
Most physicians intuitively integrate geographic information into Lyme disease management, but we demonstrate quantitatively how formal use of geographically based incidence in a clinical algorithm improves diagnostic accuracy. These findings demonstrate potential for improved outcomes from investments in health information technology that foster bidirectional communication between public health and clinical settings.
